Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)

Cardiovascular Journal of Africa

Volumn 24, Issue 7, 2013, Pages 286-289

  Maries, Lorena ^a   Manitiu, Ioan ^a  

^a LUCIAN BLAGA UNIVERSITY OF SIBIU   (Romania)

Author keywords

Natriuretic peptides; NT pro BNP; Prognostic values

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; AFRICAN AMERICAN; AGE DISTRIBUTION; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE BLOOD LEVEL; AORTA STENOSIS; BODY MASS; BRAIN NATRIURETIC PEPTIDE BLOOD LEVEL; CARDIORENAL SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; GENETIC ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; LUNG EMBOLISM; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NORMAL VALUE; OBESITY; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SUDDEN DEATH; SYSTOLIC DYSFUNCTION; UNSTABLE ANGINA PECTORIS; VALVULAR HEART DISEASE;

AGE FACTORS; BIOLOGICAL MARKERS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84889264247     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2013-055     Document Type: Review

References (25)

1. Cacciaputo F. Natriuretic Peptide System and Cardiovascular Disease. Heart Views 2010; 11(1): 10-15.
2. Burke MA, Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev 2007; 12: 23-36. (Pubitemid 46629244)
3. Coutance G, La Page O, Lo T, Hamon M. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Critical Care 2008; 12: 1-7.
4. Nunez J, Nunez E, Robies R, Bodi V, Sanchis J, Carratala A, Aprici M, Liacer A. Prognostic value of brain natiuretic peptide in acute heart failure: mortalità and hospital redmission. Rev Esp Cardiol 2008; 61:1332-1337.
5. Ajuluchukwu J, Ekure E, Mbakwem A, et al. Reliability and accuracy of point-of-care amino-terminal probrain natriuretic peptide in congestive heart failure patients. Internet J Cardiol 2010; 9(2).
6. Bernstein LH, Zions MY, Alam ME, et al. What is the best approximation of reference normal for NT-pro-BNP? Clinical levels for enhanced assessment of NT-pro-BNP (CLEAN). J Motor Learn Dev 2011; 2(2): 16-21.
7. Vaes B, Delgado V, Bax J, et al. Diagnostic accuracy of plasma NT-pro-BNP levels for excluding cardiac abnormalities in the very elderly. BMC Geriatrics 2010; 10: 85.
8. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M, ADHERE scientific advisory committee and investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-1950. (Pubitemid 46694287)
9. Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag 2010; 6: 411-418.
10. Raizada A, Bhandari S, Khan MA, et al. Brain type natriuretic peptide (BNP) - a marker of new millennium in diagnosis of congestive heart failure. Indian J Clin Biochem 2007; 22(1): 4-9. (Pubitemid 46411192)
11. Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 2004; 25: 292-299. (Pubitemid 38295437)
12. Masson S, Latini R, Arnand IS, Phil D, Barlera S, Angelici L, et al. for the Val-HeFT investigators. Prognostic value of changes in N-terminal proBNP in Val-HeFT. J Am Coll Cardiol 2008; 52: 997-1003.
13. Hartmann F, Packer M, Coats A, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004; 110: 1780-1786. (Pubitemid 39302655)
14. Castro LR, Alencar MC, Barbosa MM, Nunes Mdo C, Cardoso JR, Ribeiro AL. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome. Arq Bras Cardiol 2011; 97(6): 456-461.
15. Januzzi J, Camargo C, Anwaruddin S, et al. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Am J Cardiol 2005; 95: 948-954. (Pubitemid 40487743)
16. Booth J, Pinney J, Davenport A. N-terminal pro-BNP - marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 2010; 5: 1036-1040.
17. Baig JA, Alam JM, Ansari MA, et al. Evaluation of NT pro BNP of diagnostic significance in patients with chronic kidney diseases. Pak J Biochem Mol Biol 2010; 43(2): 99-104.
18. David S, Kumpers P, Seidler V, et al. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant 2008; 23: 1370-1377. (Pubitemid 351767474)
19. Van der Horst ICC, de Boer RA, Hillege HL, et al. Neurohormonal profile of patients with heart failure and diabetes. Netherlands Heart J 2010; 18(4): 190-196.
20. Andreas M, Zeisler H, Handisurya A, et al. N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial. Cardiovasc Diabetol 2011; 10: 28.
21. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009; 3(1): 294-304.
22. Henriksen JH, Gotze JP, Fuglsang S, et al. Increased circulating probrain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003; 52(10): 1511-1517. (Pubitemid 37176734)
23. Kneiseler G, Herzer K, Marggraf G, et al. Die Interaktion zwischen Leber und Herz. Z Herz-, Thorax- Gefäßchirurgie 2010; 24(6): 334-340.
24. Gallinat A, Neumann T, Kaiser G, et al. Brain natriuretic peptide (BNP): an early marker of cardiac dysfunction after liver transplantation? Liver Outcomes, Supplement to Transplantation 2010; 90(2S): 1739.
25. Schreiber D, Nix DA, Brown DFM et al. Natriuretic peptides in congestive heart failure. http://emedicine.medscape.com/article/761722-overview, updated: Jan 10, 2012 (accessed May 2012).